Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2014 Feb 25.
Published in final edited form as: Angew Chem Int Ed Engl. 2013 Jan 22;52(9):2569–2572. doi: 10.1002/anie.201209746

Use of a Metallopeptide Based Mimic Provides Evidence for a Proton Coupled Electron Transfer Mechanism For Superoxide Reduction By Nickel Containing Superoxide Dismutase**

Jason Shearer *
PMCID: PMC3752415  NIHMSID: NIHMS496493  PMID: 23341243

Superoxide (O2•–) is a highly toxic reactive oxygen species that can induce cellular death at subnanomolar concentrations.[1] Because O2•– is an unavoidable fact of aerobic life, aerobic organisms have evolved superoxide detoxification systems, the most prevalent of which are the superoxide dismutases (SODs).[1,2] All known SODs have redox-active metal cofactors and detoxify superoxide through a ping-pong type mechanism:

Mred+O2+2H+Mox+H2O2 (1a)
Mox+O2Mred+O2 (1b)

where Mred and Mox are the reduced and oxidized forms of the metalloenzyme's metal cofactor. The most recently discovered SOD contains nickel at its active-site (NiSOD), is found in several soil and aquatic bacteria, and operates by cycling between the reduced Ni(II) and oxidized Ni(III) oxidation states.[2f,3] In its reduced state, square planar Ni(II) is ligated by two cis-cysteinate sulfur atoms (Cys2 and Cys6), an amidate nitrogen atom from Cys2 and the N-terminal amine nitrogen atom from His1 (Scheme 1).[4] Oxidation to Ni(III) yields a square pyramidal structure via the ligation of the His1 imidazole δ-nitrogen to Ni. Thus, all of the ligating residues to Ni are contained within the first six residues of the NiSOD primary sequence.

Scheme 1.

Scheme 1

NiSOD (R = H) and NiM1 (R = CH3) active sites.

We,[3d,5] and others,[6] have exploited this convenience of nature to generate active NiSOD biomimetics by utilizing peptides containing the first 6-12 residues of the NiSOD sequence. Previously we demonstrated that one of these metallopeptide based NiSOD mimics, {Ni(SODM1H(1)HMe)} (NiM1; SODM1H(1)HMe = H2N-HMeCDLP CGVYD PA; HMe = εN-methyl-histidine), is isolable and stable at room temperature in both the Ni(II) (Ni(II)M1) and Ni(III) (Ni(III)M1) oxidation states. [5a] NiM1 also performs catalytic superoxide disproportionation at reasonably slow velocities (k = 6(1) × 106 M–1 s–1; pH = 8.0) making it an ideal candidate for detailed mechanistic study.

The mechanism by which NiSOD disproportionates superoxide has not been explore in any detail experimentally. Besides issues involving inner-sphere vs. outer-sphere O2•– oxidation/reduction, one mechanistic point that has not been explored is the role of proton donation in the superoxide reduction half-reaction (1a). Herein, we present evidence using NiM1 that superoxide disproportionation catalyzed by NiSOD can occur through a proton-coupled electron transfer (PCET) type mechanism.

We first turned our attention to the superoxide disproportionation kinetics catalyzed by NiM1 using stopped-flow techniques as previously described.[5a,7] The reaction was performed at pH 8.0 to suppress the O2•– self-disproportionation reaction. At 25.0 °C a kcat = 6.1(2) × 106 M–1 s–1 was obtained, in line with what was previously observed (Figure 1). Performing the reaction in D2O (pD = 8.0)[8] resulted in a substantial solvent KIE; the D2O kcat = 3.1(2) × 105 M–1 s–1, which translates into a solvent KIE of 20(4). Such a large room temperature KIE is suggestive of a PCET event with a substantial quantum mechanical tunneling component. We note that we measure a superoxide self-disproportionation solvent KIE of 1.2(1) under these conditions.

Figure 1.

Figure 1

Superoxide decay kinetics in the presence and absence of NiM1 at pH/pD 8.0 (25.0 °C). Data is represented by the solid lines and the second order fits are represented by the dashed lines. The gradual increase in absorbance at long time lengths is related to the H2O2 initiated decomposition of NiM1 taking place after the O2•– disproportionation is complete.

To determine if a quantum mechanical tunneling event is a tenable hypothesis we examined the temperature dependence of kcat on the NiM1 catalyzed disproportionation of superoxide. We were able to accurately determine rate constants over the temperature range of 2.0 – 75.0 °C. The Arrhenius plot of superoxide disproportionation is relatively flat, but none-the-less displays a slight concave appearance (Figure 2). A traditional Arrhenius analysis suggests a near barrierless reaction (Ea = 0.60(1) cal mole–1; A = 6.45(3) × 106 s–1). These values are wholly inconsistent with estimated and measured SOD energetics.[10] What the variable temperature kinetics data are consistent with is that SOD catalysis facilitated by NiM1 is operating via a tunneling mechanism.[11]

Figure 2.

Figure 2

Arrhenius plot of {Ni(SODM1H(1)HMe)} catalyzed decay of superoxide at pH/pD 8.0. The main plot depicts the data collected in H2O, the inset depicts the data collected in D2O. The error bars are the size of the dots or smaller. The trend lines were generated using a modified Bell Tunneling expression[11a] (see supporting information).

Based on the above experiments it seems reasonable to propose that NiM1 can facilitate the reduction of O2•– through a PCET reaction. We should therefore be able to facilitate the reduction of Ni(III)M1 with H-atom donors possessing moderate X-H bond dissociation free energies (BDFEs). Ni(III)M1 was thus subjected to a series of reactions at pH 8. We could effect the reduction of Ni(III)M1 to Ni(II)M1 using ascorbate (BDFE = 73.6 kcal mole–1)[12] and TEMPO-H (BDFE = 71.0 kcal mole–1).[12] Furthermore, Ni(III)M1 could be regenerated by adding TEMPO• to Ni(II)M1. In contrast, we could not facilitate the reduction of Ni(III)M1 utilizing reagents with slightly stronger X-H bonds, such as 1,4-dihydroquinone (first BDFE = 81.5 kcal mole–1)[12] and hydrazine (first BDFE = 83.4 kcal mole–1).[12] This would suggest that 1) there is a hydrogen atom acceptor site within Ni(III)M1 that allows for the generation of Ni(II)M1–H (i.e. protonated Ni(II)M1), and 2) that the Ni(II)M1–H BDFE is between 70 to 80 kcal mole–1.

To better estimate the Ni(II)M1–H BDFE an equilibrium reaction between TEMPO•/TEMPO-H and Ni(II)M1–H/Ni(III)M1 was established (Scheme 2). By varying the concentration of TEMPO• and Ni(II)M1–H and allowing the reaction to come to equilibrium we could calculate the equilibrium constant, K, for the reaction. At 25.0 °C we obtain a K = 26.5(8) for the Ni(III)M1 + TEMPO-H ⇌ Ni(II)M1–H + TEMPO• equilibrium process, which translates into a ΔG = –1.9(7) kcal mole–1. We can thus estimate a BDFE for the Ni(II)M1–H bond of 73(1) kcal mole–1. The measured BDFE is in line with the calculated BDFE based on the Ni(II)M1H pKa and the previously determined redox potential of NiM1 (440 mV vs. NHE).[5a] Measuring differences in the ligand-field bands of Ni(II)M1–H/ Ni(II)M1 as a function of pH yields a Ni(II)M1H pKa of ~8.2. Application of a modified Bordwell equation[12] yields a Ni(II)M1H BDFE of ~79 kcal mole–1, which is in good agreement with the above measurement considering the associated errors in the NiM1 redox potential measurement.[5a] Both of these measurements are in line with the superoxide reduction process; the deprotonated product, HO2, has an O-H BDFE of 81.6 kcal mole–1.[12] For Ni(II)M1–H to effectively facilitate the reduction of O2•– through a PCET reaction it must have a BDFE less than the HO2 O-H BDFE. Otherwise the reaction would be overall uphill and not thermodynamically viable.

Scheme 2.

Scheme 2

Equilibrium reaction between Ni(III)M1 + TEMPO-H and Ni(II)M1-H + TEMPO•

If there is an abstractable H-atom within Ni(II)M1–H, then there must be a well defined protonation site near the Ni(II) active site. An initial clue to the location of the well-defined protonation site within Ni(II)M1–H was provided by Ni K-edge X-ray absorption spectroscopy (XAS) recorded at elevated pH. Previously we demonstrated that at pH 7.4 Ni(II)M1–H has an average Ni-S bond length of 2.18 Å.[5a] At pH 9.5 Ni(II)M1 has an average Ni-S bond length of 2.20 Å. This increase in bond length is consistent with a thiolate deprotonation event.[13a] Although counterintuitive, the origin of the contraction of the Ni-S bond in square planar Ni(II)N2S2 complexes upon protonation or hydrogen-bond formation is well know.[13] Prontonation of the coordinated S via a filled S(p)-type lone-pair reduces unfavorable filled-filled Ni(π)/S(π) interactions leading to a bond contraction. Thus, the elongation of the Ni-S bond at high pH is consistent with cysteinate deprotonation.

A protonated Ni-S(H)-Cys bond is also consistent with room temperature S K-edge XAS performed at pH 7.4 vs. 9.5. At pH 9.5 the S K-edge X-ray absorption spectrum of Ni(II)M1 is consistent with a thiolate ligated Ni(II) complex (Figure 3).[14] The main S(1s) → S(C-Sσ*) transition occurs at 2472.6(1) eV. Prior to the S(1s) → S(C-Sσ*) transition there is a prominent pre-edge feature corresponding to the nominal S(1s) → Ni(3d)/S(σ)* transition at 2470.4(1) eV. Similarly, the pH 7.4 S K-edge spectrum of oxidized Ni(III)M1 is consistent with a thiolate ligated Ni(III) complex; the main S(1s) → S(C-Sσ*) transition occurs at 2473.0(1) eV while the S(1s) → Ni(3d)/S transitions at ~2470 eV is broad, displays asymmetry and is more intense. The change in intensity and peak shape is consistent with a) the increase in number of holes in the Ni(3d) manifold from 2 to 3 upon oxidation and b) the fact that a lower-energy Ni(3d)/S(π)* type orbital is now only partially filled and will accept an electron upon promotion from the S1(s) orbital. These two spectra can be contrasted with the pH 7.4 S K-edge X-ray absorption spectrum of Ni(II)M1–H. First, there is a broadening of the main S(1s) → S(C-Sσ*) transition. Second, and more obvious, the pre-edge feature virtually disappears into the baseline. There are three conclusions that can be drawn from these results. One is that the pH 7.4 form of Ni(II)M1–H is protonated at one (or both) of the coordinated cysteinates.[15] The second conclusion is that at pH 9.5 the coordinated cysteinate(s) become deprotonated. The last conclusion is that Ni(III)M1 does not contain a protonated coordinated cysteinate at low pH.

Figure 3.

Figure 3

Sulfur K-edge XAS spectra of Ni(II)M1–H recorded at pH 7.4 (solid), Ni(II)M1 recorded at pH 9.5 (dotted), and Ni(III)M1 recorded at pH 7.4 (dashed).

It seems reasonable to propose that the source of the formal H-atom in reduced Ni(II)M1–H is a protonated Ni(II)-S(H)Cys moiety. One may expect that the pKa of a coordinated thiolate would be rather low and inconsistent with this formulation. However, we suspect that the cis-Cys moiety, or possibly the coordinated amine cis to the Cys residue, may substantially raise the pKa of the Ni(II)-S(H)Cys moiety higher than expected through a cooperative effect as seen in 1,8-bis(dimethylamino)naphthalene (proton sponge), for example. Other structural factors in metallopeptide microenvironment about Ni(II) center may also be contributing to the elevated Ni(II)-S(H)Cys pKa.

In summary, we have provided evidence that superoxide disproportionation catalyzed by NiM1 occurs through a rate-limiting PCET mechanism with a significant tunneling component. It appears that the PCET step occurs during the reduction of O2•– by protonated Ni(II)M1–H, and the formal H-atom is in the form of a coordinated Ni(II)-S(H)Cys moiety (Scheme 3). This proposal of a PCET mechanism during superoxide reduction appears to be unique amongst the SODs, save a recent study of Cu/Zn-SOD (vide infra).

Scheme 3.

Scheme 3

Proposed mechanism of O2•– reduction by {NiII(SODM1H(1)HMe)-H} and NiSOD.

Computationally, there has been one hybrid DFT study that has explicitly invoked a PCET event during the NiSOD catalyzed reduction of O2•–.[16] In that study the transferred “H-atom” is in the form of a Ni-S(H)-Cys moiety. Our findings are also consistent with the limited experimental data available concerning NiSOD itself, as well as some more recent studies on Cu/Zn SOD. First, there is strong evidence from S K-edge X-ray absorption spectroscopy that reduced NiSOD itself contains a protonated Ni(II)-S(H)Cys moiety while the cysteinate is deprotonated upon NiSOD oxidation.[15] Second, the crystal structure of NiSOD reveals an unusual structural feature; the Ni-S bond trans to the amidate nitrogen is shorter than the Ni-S bond trans to the amine nitrogen.[4] This is the opposite of what one would expect based on the synthetic Ni(II)N2S2 models with amine vs. amidate coordination.[13a,b,17] It therefore seems reasonable to suggest that the Ni-SCys moiety trans to the amidate is indeed protonated in NiSOD. Analysis of the pH dependence of SOD catalysis by NiSOD itself shows that kcat is pH independent over the range of 6-8 and then falls off dramatically above 8.0, which is suggestive of the strong coupling of the proton-transfer event with the redox chemistry of O2•–.[3c] Lastly, we note that at least one other SOD appears to operate through a rate-limiting PT event. A recent natural abundance 18O/16O KIE study by Roth and Smirnov provided evidence that an initial rate limiting proton transfer event is occurring in the reduction of O2•– by Cu/Zn SOD under high pH conditions.[10a] We are currently in the process of determining the extent to which H-atom transfer from a Mred-S(H)Cys moiety is relevent in NiSOD itself as well as other metalloenzymes, such as [Ni,Fe]-hydrogenase.[18]

Supplementary Material

Supporting Information

Footnotes

**

This work was supported by the National Science Foundation (CHE-0844234). X-ray absorption measurements were collected on X19a and X3b at the National Synchrotron Light Source (NSLS) which is funded by the DOE (contract no. DE-AC02-98CH10886). Work on X3b, which is part of the Case Center for Synchrotron Bioscience, was also supported by the NIH (P30-EB-009998). Profs. J. Mayer (Univ. of Washington), H.K. Shin (UNR) and an anonymous reviewer are acknowledged for valuable advice.

Supporting information for this article is available on the WWW under http://www.angewandte.

References

  • 1.Kurtz DM., Jr. Acc. Chem. Res. 2004;37:902–908. doi: 10.1021/ar0200091. [DOI] [PubMed] [Google Scholar]
  • 2.a McCord JM, Fridovich I. J. Biol. Chem. 1969;244:6049–6055. [PubMed] [Google Scholar]; b Fridovich I. Acc. Chem. Res. 1972;5:321–326. [Google Scholar]; c Hart PJ, Balbirnie MM, Ogihara NL, Nersissian AM, Weiss MS, Valentine JS, Eisenberg D. Biochemistry. 1999;38:2167–2178. doi: 10.1021/bi982284u. [DOI] [PubMed] [Google Scholar]; d Barnese K, Sheng Y, Stich TA, Gralla EB, Britt RD, Cabelli DE, Valentine JS. J. Am. Chem. Soc. 2010;132:12525–12527. doi: 10.1021/ja104179r. [DOI] [PMC free article] [PubMed] [Google Scholar]; e Vance CK, Miller A-F. Biochemistry. 1998;37:5518–5527. doi: 10.1021/bi972580r. [DOI] [PubMed] [Google Scholar]; f Choudhury SB, Lee J-W, Davidson G, Yim Y-L, Bose K, Sharma ML, Kang S-O, Cabelli DE, Maroney MJ. Biochemistry. 1999;38:3744–3752. doi: 10.1021/bi982537j. [DOI] [PubMed] [Google Scholar]
  • 3.a Youn HD, Kim EJ, Roe JH, Hah YC, Kang SO. Biochem. J. 1996;318:889–896. doi: 10.1042/bj3180889. [DOI] [PMC free article] [PubMed] [Google Scholar]; b Youn HD, Youn H, Lee JW, Yim YI, Lee JK, Kang YCSO. Arch. Biochem. Biophys. 1996;334:341–348. doi: 10.1006/abbi.1996.0463. [DOI] [PubMed] [Google Scholar]; c Palenik B, Brahamsha B, Larimer FW, Land M, Hauser L, Chain P, Lamerdin J, Regala W, Allen EE, McCarren J, Paulsen I, Dufresne A, Partensky F, Webb EA, Waterbury J. Nature. 2003;424:1037–1042. doi: 10.1038/nature01943. [DOI] [PubMed] [Google Scholar]; d Dupont CL, Neupane K, Shearer J, Palenik B. Environ. Microbiol. 2008;10:1831–1843. doi: 10.1111/j.1462-2920.2008.01604.x. [DOI] [PubMed] [Google Scholar]
  • 4.a Barondeau DP, Kassmann CJ, Bruns CK, Tainer JA, Getzoff ED. Biochemistry. 2004;43:8038–8047. doi: 10.1021/bi0496081. [DOI] [PubMed] [Google Scholar]; b Wuerges J, Lee J-L, Yim Y-I, Yim H-S, Kang S-O, Carugo KD. Proc. Natl. Acad. Sci. U.S.A. 2004;101:8569–8574. doi: 10.1073/pnas.0308514101. [DOI] [PMC free article] [PubMed] [Google Scholar]; c Herbst RW, Guce A, Bryngelson PA, Higgins KA, Ryan KC, Cabelli DE, Garman SC, Maroney MJ. Biochemistry. 2009;48:3354–3369. doi: 10.1021/bi802029t. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.a Shearer J, Neupane KP, Callan PE. Inorg. Chem. 2009;48:10560–10571. doi: 10.1021/ic9010407. [DOI] [PMC free article] [PubMed] [Google Scholar]; b Shearer J, Long L. Inorg. Chem. 2006;45:2358–2360. doi: 10.1021/ic0514344. [DOI] [PubMed] [Google Scholar]; c Neupane KP, Gearty K, Francis A, Shearer J. J. Am. Chem. Soc. 2007;129:14605–14618. doi: 10.1021/ja0731625. [DOI] [PubMed] [Google Scholar]; d Neupane KP, Shearer J. Inorg. Chem. 2006;45:10552–10566. doi: 10.1021/ic061156o. [DOI] [PubMed] [Google Scholar]
  • 6.a Schmidt M, Zahn S, Carella M, Ohlenschlaeger O, Goerlach M, Kothe E, Weston J. ChemBioChem. 2008;9:2135–2146. doi: 10.1002/cbic.200800017. [DOI] [PubMed] [Google Scholar]; b Tietze D, Breitzke H, Imhof D, Kothe E, Weston J, Buntkowsky G. Chem.–Eur. J. 2009;15:517–523. doi: 10.1002/chem.200800870. [DOI] [PubMed] [Google Scholar]
  • 7.KO2 was solubilised in DMSO with 18-crown-6 and mixed with a buffer solution of Ni(II)M1 during the stopped-flow experiment. To minimize the optical disturbance of DMSO mixing with the buffer a final 15:1 buffer:DMSO ratio was used. Riley DP, Rivers WJ, Weiss RH. Anal Biochem. 1991;196:344–349. doi: 10.1016/0003-2697(91)90476-a.
  • 8.Superoxide decay kinetics catalyzed by NiM1 recorded at pH 9.0 have rate constants of over an order of magnitude lower than those determined at pH 8.0.
  • 9.We note that pD values were adjusted for differences in readings from the pH meter for H2O vs. D2O solutions and pKa differences so [H+] and [D+] would be equal in the kinetics experiments. Fersht A. Structure and Mechanism in Protein Science. W.H. Freeman and Company; New York: 1999. p. 185.
  • 10.a Smirnov VV, Roth JP. J. Am. Chem. Soc. 2006;128:16424–16425. doi: 10.1021/ja066369r. [DOI] [PubMed] [Google Scholar]; b Padiglia A, Medda R, Cruciani E, Lorrai A, Floris G. Prep Biochem Biotechnol. 1996;26:135–142. doi: 10.1080/10826069608000059. [DOI] [PubMed] [Google Scholar]; c Takahashi M, Asada K. J. Biochemistry. 1982;91:889–896. doi: 10.1093/oxfordjournals.jbchem.a133777. [DOI] [PubMed] [Google Scholar]
  • 11.a Limbach HH, Lopez JM, Kohen A. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2006;361:1399–1415. doi: 10.1098/rstb.2006.1872. [DOI] [PMC free article] [PubMed] [Google Scholar]; b Liang ZX, Klinman JP. Curr. Opin. Struct. Biol. 2004;14:648–655. doi: 10.1016/j.sbi.2004.10.008. [DOI] [PubMed] [Google Scholar]
  • 12.Warren JJ, Tronic TA, Mayer JM. Chem. Rev. 2010;110:6961–7001. doi: 10.1021/cr100085k. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.a Grapperhaus CA, Darensbourg MY. Acc. Chem. Res. 1998;31:451–459. [Google Scholar]; b Gale EM, Narendrapurapu BS, Simmonett AC, Schaefer HF, III, Harrop TC. Inorg. Chem. 2010;49:7080–7096. doi: 10.1021/ic1009187. [DOI] [PubMed] [Google Scholar]; c Fiedler AT, Bryngelson PA, Maroney MJ, Brunold TC. J. Am. Chem. Soc. 2005;127:5449–5462. doi: 10.1021/ja042521i. [DOI] [PubMed] [Google Scholar]; d Allan CB, Davidson G, Choudhury SB, Gu ZJ, Bose K, Day RO, Maroney MJ. Inorg. Chem. 1998;37:4166–4167. doi: 10.1021/ic9804465. [DOI] [PubMed] [Google Scholar]
  • 14.Glasser T, Hedman B, Hodgson KO, Solomon EI. Acc. Chem. Res. 2000;33:859–868. doi: 10.1021/ar990125c. [DOI] [PubMed] [Google Scholar]
  • 15.Szilagyi RK, Bryngelson PA, Maroney MJ, Hedman B, Hodgson KO, Solomon EI. J. Am. Chem. Soc. 2004;126:3018–3019. doi: 10.1021/ja039106v. [DOI] [PubMed] [Google Scholar]
  • 16.Pelmenschikov V, Siegnahn PEM. J. Am. Chem. Soc. 2006;128:7466–7475. doi: 10.1021/ja053665f. [DOI] [PubMed] [Google Scholar]
  • 17.a Shearer J, Zhao N. Inorg. Chem. 2006;45:9637–9639. doi: 10.1021/ic061604s. [DOI] [PubMed] [Google Scholar]; b Krüger H-J, Peng G, Holm RH. Inorg. Chem. 1991;30:734–742. [Google Scholar]
  • 18.Weber K, Krämer T, Shafaat H, Weyhermüller T, Bill E, van Gastel M, Neese F, Lubitz W. J. Am. Chem. Soc. 2012;134:20745–20755. doi: 10.1021/ja309563p. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supporting Information

RESOURCES